Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostar plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone for locally advanced cervical cancer
ChiCTR2000040892Phase 4Completed
- Sponsor
- Guangxi Zhuang Autonomous Region People's Hospital
- Start
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of endostar in Cervical Cancer (CC) (2 arms), sponsored by Guangxi Zhuang Autonomous Region People's Hospital. Primary endpoints: Progression-free survival and Acute toxicity. Started Jan 2017; status: completed.
02
Drugs
endostar
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2000040892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040892.